Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
---|
07/08/2010 | US20100173413 Pyridine compounds |
07/08/2010 | US20100173028 Process for preparing vitis vinifera pip extract and pharmaceutical composition for preventing or treating rheumatoid arthritis comprising the same |
07/08/2010 | US20100172983 Pharmaceutical Compositions for the Coordinated Delivery of Naproxen and Esomeprazole |
07/08/2010 | US20100172981 Ibuprofen-Effervescent Preparation Having a High Dissolution Rate and Method for the Production thereof |
07/08/2010 | US20100172974 Melt-extruded orally administrable opioid formulations |
07/08/2010 | US20100172959 Reservoir system with closed membrane |
07/08/2010 | US20100172912 Methods of therapy for b-cell malignancies using antagonist anti-cd40 antibodies |
07/08/2010 | US20100172911 Methods and Vectors for Generating Asialylated Immunoglobulins |
07/08/2010 | US20100172905 Antagonists of hmg1 for treating inflammatory conditions |
07/08/2010 | US20100172904 Mcp1 fusions |
07/08/2010 | US20100172902 Method for treating a vcam-1 mediated disease |
07/08/2010 | US20100172892 Hyaluronidase and method of use thereof |
07/08/2010 | CA2748729A1 Sulfated c-glycoside, method for isolating same and method for synthesizing same |
07/08/2010 | CA2747310A1 Methods of identifying critically ill patients at increased risk of development of organ failure and compounds for the treatment hereof |
07/08/2010 | CA2747094A1 Substituted 4-(1,2,3,4-tetrahydroisoquinolin-2-yl)-4-oxobutyric acid amide as kcnq2/3 modulators |
07/08/2010 | CA2746295A1 N-(1-phenyl-2-arylethyl)-4,5-dihydro-3h-pyrrol-2-amine compounds as subtype selective modulators of alpha2b or alpha2b and alpha2c adrenoceptors |
07/08/2010 | CA2746220A1 Compositions of protein receptor tyrosine kinase inhibitors |
07/07/2010 | EP2204192A1 Prophylactic or therapeutic agent for inflammatory disease comprising thymidine phosphorylase inhibitor as active ingredient |
07/07/2010 | EP2204181A2 Protease inhibitors |
07/07/2010 | EP2204175A1 Therapeutic agent for inflammatory bowel disease comprising uracil derivative as active ingredient |
07/07/2010 | EP2203440A1 Inhibitors of the interaction between mdm2 and p53 |
07/07/2010 | EP2203435A2 6, 11-bridged biaryl macrolides |
07/07/2010 | EP2203429A1 Pyridazinone derivatives and use thereof as p2x7 receptor inhibitors |
07/07/2010 | EP2203057A1 Method and compositions for treatment or prevention of inflammatory conditions |
07/07/2010 | EP1485099B1 Inhibitors of histone deacetylase |
07/07/2010 | EP1392301B1 Prevention of addiction in pain management with gamma vinyl gaba |
07/07/2010 | EP1383919B1 Methods and compositions for using mhc class ii invariant chain polypeptide as a receptor for macrophage migration inhibitory factor |
07/07/2010 | EP1274834B1 HUMAN AMINOACYL-tRNA SYNTHETASE POLYPEPTIDES USEFUL FOR THE REGULATION OF ANGIOGENESIS |
07/07/2010 | CN1942469B Condensed pyridine derivatives useful as A28 adenosine receptor antagonists |
07/07/2010 | CN101772507A proteasome inhibitors |
07/07/2010 | CN101772499A Tricyclic N-heteroaryl-carboxamide derivatives, preparation thereof and therapeutic use of same |
07/07/2010 | CN101772498A Heteroaryl amide analogues as p2x7 antagonists |
07/07/2010 | CN101772497A New crystalline forms of 2 -hydroxy- 3- [5- (morpholin- 4- ylmethyl) pyridin-2-yl] ih- indole- 5 -carbonitrile citrate |
07/07/2010 | CN101768516A Tangerine oil and preparation method and application thereof |
07/07/2010 | CN101768152A Piperidine derivatives useful as CCR5 antagonists |
07/07/2010 | CN101768147A Chrysin and substituted salicylate composites, manufacturing method thereof and use thereof |
07/07/2010 | CN101766822A Piroxicam beta-cyclodextrin inclusion compounds and preparation method of tablets thereof |
07/07/2010 | CN101766808A Method for obtaining series analgesic active peptides DKK and analogs thereof and application of series analgesic active peptide DKK and analogs thereof |
07/07/2010 | CN101766806A Application of CRISPLD2 protein in aspect of inflammation |
07/07/2010 | CN101766791A Chinese herbal composite for fever treatment and preparation method thereof |
07/07/2010 | CN101766787A Enema liquid for treating hyperpyrexia and cough and asthma |
07/07/2010 | CN101766773A Chinese medicine prescription for treating talagia |
07/07/2010 | CN101766767A Chinese medicine composition for headaches |
07/07/2010 | CN101766750A Chinese medicine conditioning powder for bathing |
07/07/2010 | CN101766746A External bee venom liniment |
07/07/2010 | CN101766742A Chinese herbal regulation patch |
07/07/2010 | CN101766729A Damp-clearing pain-relieving liquor and acupoint application treatment method |
07/07/2010 | CN101766724A Chinese medicine preparation for treating traumatic injury and rheumatic pain and preparation method thereof |
07/07/2010 | CN101766723A Chinese medicine preparation for treating traumatic injury and rheumatic pain and preparation method thereof |
07/07/2010 | CN101766710A Chinese medicine preparation for quickly curing burns and scalds without no scars and preparation method thereof |
07/07/2010 | CN101766708A Quality control method of Chinese herbal preparation for rheumatism treatment |
07/07/2010 | CN101766706A Medicinal combination containing borneol and musk |
07/07/2010 | CN101766705A Medicinal combination containing borneol and musk |
07/07/2010 | CN101766704A Medicinal combination containing borneol and musk |
07/07/2010 | CN101766703A Medicinal combination containing borneol and musk |
07/07/2010 | CN101766702A Medicinal combination containing borneol and musk |
07/07/2010 | CN101766701A Medicinal combination containing musk |
07/07/2010 | CN101766700A Medicinal combination containing musk |
07/07/2010 | CN101766699A Medicinal combination containing musk |
07/07/2010 | CN101766692A Channel-freeing harmonizing emulsion |
07/07/2010 | CN101766687A Inflammation diminishing capsules prepared from baical skullcap root and golden thread and preparation method thereof |
07/07/2010 | CN101766682A Process for extracting and purifying total alkaloids of Sophora alopecuroides |
07/07/2010 | CN101766680A Comprehensive extraction method of glycyrrhiza |
07/07/2010 | CN101766669A Chinese medicament for treating injuries from falls |
07/07/2010 | CN101766664A Extraction method of total saponin of Radix Ilicis Asprellae and quality detection method thereof |
07/07/2010 | CN101766663A Chinese medicine preparation for external use for rheumatoid arthritis treatment |
07/07/2010 | CN101766662A Process for efficiently concentrating cordycepin |
07/07/2010 | CN101766651A Purpose of corbicula water extract |
07/07/2010 | CN101766646A Basifying liquid medicine for treating aseptic inflammatory pain |
07/07/2010 | CN101766640A Preparation for panaxoside-Rd aqueous solution of propylene glycol and new application thereof in inflammation resistance, immune suppression and organ transplant rejection resistance |
07/07/2010 | CN101766585A Medical paste film |
07/07/2010 | CN101766572A Normal pressure anti-solvent preparation method for water-soluble glycyrrhizic acid powder |
07/07/2010 | CN101766422A Brassica campestris L. seed health-care pillow and manufacturing method thereof |
07/07/2010 | CN101766228A Iimmune stimulatory infant nutrition |
07/07/2010 | CN101229141B Aspirin sustained release tablet and preparing method thereof |
07/07/2010 | CN101015543B Use of cinnamic acid and allyl benzoate compound with oxidation resistance function for protecting liver and brain damage |
07/06/2010 | US7750016 Hydroxyalkyl substituted pyrido-7-pyrimidin-7-ones |
07/06/2010 | US7750015 Nitrogen-containing heterocyclic compounds and methods of use thereof |
07/06/2010 | US7750011 Diazabicyclic aryl derivatives and their medical use |
07/06/2010 | US7750000 Substituted imidazo[1,2b]pyridazines as kinase inhibitors, their preparation and use as medicaments |
07/06/2010 | US7749960 An enteral composition or a pharmaceutical containing osteoprotegerin obtained from human or bovine milk or colostrum; preventing or treating disorders associated with bone metabolism and immune function |
07/06/2010 | US7749753 modulation of transport proteins in biological cells; genetic engineering; antibodies |
07/06/2010 | US7749752 Using vector comprisng nucleotide sequences coding cell binding elements to transform cells and identify lymphocyte response modulators |
07/06/2010 | US7749718 Method for raising or isolating an antibody to DCRS5 |
07/06/2010 | US7748379 Methods and apparatus for relieving headaches, rhinitis and other common ailments |
07/06/2010 | CA2587792C Therapeutic compositions for intranasal administration of ketorolac |
07/06/2010 | CA2460222C Eustachian tube stent |
07/06/2010 | CA2446149C Vitamin d analogues |
07/06/2010 | CA2437109C Novel benzamidine derivatives having anti-inflammatory and immunosuppressive activity |
07/06/2010 | CA2393883C Salicylamide derivatives |
07/06/2010 | CA2370814C Method for the treatment of fibrosis using an antagonist of the integrin alpha-4 subunit |
07/06/2010 | CA2365844C Texture masked particles containing an active ingredient |
07/06/2010 | CA2333188C Multiparticulate pharmaceutical form with programmed and timed release and preparation method |
07/06/2010 | CA2295572C Treatment of inflammatory disorders of the bowel and urinary bladder |
07/01/2010 | WO2010075423A2 Dendrimer based modular platforms |
07/01/2010 | WO2010075287A2 Compounds and methods for the treatment of pain and other diseases |
07/01/2010 | WO2010075270A1 4, 6-disubstituted 2-amino-pyrimidines as histamine h4 receptor modulators |
07/01/2010 | WO2010075200A1 7-phenoxychroman carboxylic acid derivatives |
07/01/2010 | WO2010075069A1 Bicyclic pyranone derivatives as nicotinic acid receptor agonists |
07/01/2010 | WO2010074453A2 Composition for treating gout, containing angelica gigas extract having a xanthine oxidase-inhibiting effect and an inflammation-inducing enzyme-inhibiting effect |